The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations.

The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations. This brochure provides healthcare professionals with an understanding of the clinical utility and benefits of IPV therapy as demonstrated in the available evidence.

By overcoming the limitations of end-tidal CO2 and providing better compatibility with all modes of ventilation, transcutaneous CO2 monitoring helps clinicians assess patient condition and the efficacy of treatment and ventilatory support strategies.

Transcutaneous CO2 monitoring (tcPCO2) is considered by many neonatal teams to be standard of care in the NICU for intubated patients – but many children’s hospitals utilize this technology across many more patient types and care settings. This document explores tcPCO2 in clinical settings, demonstrating the impact that this technology can have throughout a children’s hospital.

With a full suite of devices, IPV therapy is designed to support a wide range of patients facing these respiratory challenges — providing seamless care from hospital to home.

IPV therapy is a safe and well-tolerated airway clearance therapy that can be used with a diverse set of patient populations, care settings, and delivery interfaces.

This whitepaper discusses three pediatric patient populations that are difficult to manage on mechanical ventilation and how continuous monitoring of CO2 can serve as a powerful tool to support noninvasive ventilation (NIV) strategies and therapies in the PICU.